Aerosolized soluble nitric oxide donor improves oxygenation and pulmonary hypertension in acute lung injury

American Journal of Respiratory and Critical Care Medicine

Volumn 158, Issue 5 PART I, 1998, Pages 1536-1542

  Jacobs, Brian R ^a   Brilli, Richard J ^b   Ballard, Edgar T ^b   Passerini, Daniel J ^b   Smith, Daniel J ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GAS EXCHANGE; HEMODYNAMICS; LUNG FUNCTION; LUNG INJURY; LUNG VASCULAR RESISTANCE; MALE; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

ADMINISTRATION, INHALATION; AEROSOLS; AMINO ACIDS, DIAMINO; ANIMALS; CARDIAC OUTPUT; CATHETERIZATION, SWAN-GANZ; DISEASE MODELS, ANIMAL; HEART CATHETERIZATION; HYPERTENSION, PULMONARY; INJECTIONS, INTRAVENOUS; LUNG; MALE; METHEMOGLOBIN; NEBULIZERS AND VAPORIZERS; NITRATES; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRITES; OLEIC ACID; OXYGEN CONSUMPTION; PULMONARY GAS EXCHANGE; RANDOM ALLOCATION; RESPIRATORY DISTRESS SYNDROME, ADULT; SOLUBILITY; SWINE; VASCULAR RESISTANCE; VASODILATOR AGENTS; VENTILATION-PERFUSION RATIO;

EID: 0031790333     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.158.5.9802114     Document Type: Article

References (43)

1. Villar, J., and A. S. Slutsky. 1989. The incidence of the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 140:814-816.
2. Webster, N. R., A. T. Cohen, and J. F. Nunn. 1988. Adult respiratory distress syndrome - how many cases in the UK? Anaesthesia 43:923-926.
3. Thomsen, G. E., and A. H. Morris. 1995. Incidence of the adult respiratory distress syndrome in the State of Utah. Am. J. Respir. Crit. Care Med. 152:965-971.
4. Lewandowski, K., J. Metz, C. Deutschmann, H. Preib, R. Kuhlen, A. Artigas, and K. J. Falke. 1995. Incidence, severity, and mortality of acute respiratory failure in Berlin, Germany. Am. J. Respir. Crit. Care Med. 151:1121-1125.
5. Davis, S. L., D. P. Furman, and A. J. Costarino. 1993. Adult respiratory distress syndrome in children: associated disease, clinical course, and predictors of death. J. Pediatr. 123:35-45.
6. Timmons, O. D., P. L. Havens, and J. C. Fackler. 1995. Predicting death in pediatric patients with acute respiratory failure. Chest 108:789-797.
7. Katz, R. 1987. Adult respiratory distress syndrome in children. Clin. Chest Med. 8:635-639.
8. Timmons, O. D., J. M. Dean, and D. D. Vernon. 1991. Mortality rates and prognostic variables in childred with adult respiratory distress syndrome. J. Pediatr. 119:896-899.
9. Zapol, W. M., and M. T. Snider. 1977. Pulmonary hypertension in severe acute respiratory failure. N. Engl. J. Med. 296:476-480.
10. Katz, R., M. Pollack, and D. Spady. 1984. Cardiorespiratory abnormalities in severe acute respiratory failure. J. Pediatr. 104:357-364.
11. Pearl, R. G., M. H. Rosenthal, and J. P. A. Ashton. 1983. Pulmonary vasodilator effects of nitroglycerin and sodium nitroprusside in canine oleic acid-induced pulmonary hypertension. Anesthesiology 58:514-518.
12. Colley, P. S., F. W. Chaney, and M. P. Hlastala. 1981. Pulmonary gas exchange effects of nitroglycerin in canine edematous lungs. Anesthesiology 55:114-119.
13. 1 in patients with the adult respiratory distress syndrome. Chest 96:114-119.
14. Shah, N. S., D. K. Nakayama, T. D. Jacob, I. Nishio, T. Imai, T. R. Billiar, R. Exler, S. A. Yousem, E. K. Motoyama, and A. B. Peitzman. 1994. Efficacy of inhaled nitric oxide in a porcine model of adult respiratory distress syndrome. Arch. Surg. 129:153-158.
15. Pison, U., F. A. López, C. F. Heidelmeyer, R. Rossaint, and K. J. Falke. 1993. Inhaled nitric oxide reverses hypoxic pulmonary vasoconstriction without impairing gas exchange. J. Appl. Physiol. 74:1287-1292.
16. Rossaint, R., K. J. Falke, F. Lopez, K. Slama, U. Pison, and W. M. Zapol. 1993. Inhaled nitric oxide for the adult respiratory distress syndrome. N. Engl. J. Med. 328:399-405.
17. Zapol, W. M., K. J. Falke, and R. Rossaint. 1993. Inhaled nitric oxide for the adult respiratory distress syndrome. N. Engl. J. Med. 329:207.
18. Abman, S. H., J. L. Griebel, D. K. Parker, J. M. Schmidt, D. Swanton, and J. P. Kinsella. 1994. Acute effects of inhaled nitric oxide in children with severe hypoxemic respiratory failure. J. Pediatr. 124:881-888.
19. Morley, D., and L. K. Keefer. 1993. Nitric oxide/nucleophile complexes: a unique class of nitric oxide-based vasodilators. J. Cardiovasc. Pharmacol. 22(Suppl. 7):S3-S9.
20. -: O-functionalization chemistry. J. Org. Chem. 57:6134-6138.
21. Brilli, R. J., B. Krafte-Jacobs, D. J. Smith, D. Roselle, D. Passerini, A. Vromen, L. Moore, C. Szabó, and A. Salzman. 1997. Intratracheal instillation of a novel NO/nucleophile selectively reduces pulmonary hypertension. J. Appl. Physiol. 83:1968-1975.
22. Brilli, R. J., B. Krafte-Jacobs, D. Smith, D. Passerini, L. Moore, and E. T. Ballard. 1998. Aerosolization of novel nitric oxide donors selectively reduce pulmonary hypertension. Crit. Care Med. 26:1390-1396.
23. Grotjohan, H. P., R. M. J. L. Van Der Heijde, C. A. Wagenvoort, N. Wagenvoort, and A. Versprille. 1993. Pulmonary vasoconstriction in oleic acid induced lung injury: a morphometric study. Int. J. Exp. Pathol. 74:347-355.
24. Maragos, C. M., D. Morley, D. A. Wink, T. M. Dunams, J. E. Saavedra, A. Huffman, A. A. Bove, L. Isaac, J. A. Hrabie, and L. K. Keefer. 1991. Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide: vasorelaxant effects. J. Med. Chem. 34:3242-3247.
25. 15N] nitrate in biological fluids. Anal. Biochem. 126:131-138.
26. Krafte-Jacobs, B., R. J. Brilli, C. Szabó, A. Denenberg, L. Moore, and A. L. Salzman. 1997. Circulating methemoglobin, and nitrite/nitrate concentrations as indicators of nitric oxide overproduction in critically ill children with septic shock. Crit. Care Med. 25:1588-1593.
27. Broccard, A. F., R. S. Shaprio, L. L. Schmitz, S. A. Ravenscraft, and J. J. Marini. 1997. Influence of prone postion on the extent and distribution of lung injury in a high tidal volume oleic acid model of acute respiratory distress syndrome. Crit. Care Med. 25:16-27.
28. Frostell, C., M. D. Fratacci, J. C. Wain, R. Jones, and W. M. Zapol. 1991. Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 83:2038-2047.
29. Lavoie, A., J. B. Hall, D. M. Olson, and M. E. Wylam. 1996. Life-treatening effects of discontinuing inhaled nitric oxide in severe respiratory failure. Am. J. Respir. Crit. Care Med. 153:1985-1987.
30. Dantzker, D. R., C. J. Brook, P. Dehart, J. P. Lynch, and J. G. Weg. 1979. Ventilation-perfusion distributions in the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 120:1039-1052.
31. Lamy, M., R. J. Fallat, E. Koeniger, H. P. Dietrich, J. L. Ratliff, R. C. Eberhart, H. J. Tucker, and J. D. Hill. 1976. Pathologic features and mechanisms of hypoxemia in adult respiratory distress syndrome. Am. Rev. Respir. Dis. 114:267-284.
32. Demirakça, S., J. Dötsch, C. Knothe, J. Magsaam, H. L. Reiter, J. Bauer, and P. G. Kuehl. 1996. Inhaled nitric oxide in neonatal and pediatric acute respiratory distress syndrome: dose response, prolonged inhalation, and weaning. Crit. Care Med. 24:1913-1919.
33. Rossetti, M., H. Guénard, and C. Gabinski. 1996. Effects of nitric oxide inhalation on pulmonary serial vascular resistances in ARDS. Am. J. Respir. Crit. Care Med. 154:1375-1381.
34. Ogura, H., D. Saitoh, A. A. Johnson, A. D. Mason, Jr., B. A. Pruitt, Jr., and W. G. Cioffi, Jr. 1994. The effect of inhaled nitric oxide on pulmonary ventilation-perfusion matching following smoke inhalation injury. J. Trauma 37:893-598.
35. Lewis, J. F., B. Tabor, M. Ikegami, A. H. Jobe, M. Joseph, and D. Absolom. 1993. Lung function and surfactant distribution in saline lavaged sheep given instilled vs. nebulized surfactant. J. Appl. Physiol. 74:1256-1264.
36. Nakagawa, T. A., A. Morris, R. J. Gomez, S. J. Johnston, P. T. Sharkey, and A. L. Zaritsky. 1997. Dose response to inhaled nitric oxide in pediatric patients with pulmonary hypertension and acute respiratory distress syndrome. J. Pediatr. 131:63-69.
37. Gerlach, H., R. Rossaint, D. Pappert, and K. J. Falke. 1993. Time course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur. J. Clin. Invest. 23:499-502.
38. Beckman, J. S., and W. H. Koppenol. 1996. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol. 271:C1424-C1437.
39. Nishimura, M., D. Hess, R. M. Kacmarek, R. Ritz, and W. E. Hurford. 1995. Nitrogen dioxide production during mechanical ventilation with nitric oxide in adults. Anesthesiology 82:1246-1254.
40. Greenbaum, R., J. Bay, M. D. Hargreaves, M. L. Kain, G. R. Kelman, J. F. Nunn, C. Prys-Roberts, and K. Siebold. 1967. Effects of higher oxides of nitrogen on the anaesthetized dog. Br. J. Anaesth. 39:393-403.
41. 2 exposure on alveolar permeability and glutathione peroxidase in healthy humans. Am. Rev. Respir. Dis. 146:654-659.
42. Romand, J. A., M. R. Pinsky, L. Firestone, H. A. Zar, and J. R. Lancaster, Jr. 1994. Effect of inhaled nitric oxide on pulmonary hemodynamics after acute lung injury in dogs. J. Appl. Physiol. 76:1356-1362.
43. Freeman, B. 1994. Free radical chemistry of nitric oxide: looking at the dark side. Chest 105(Suppl.):79S-84S.